Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

557
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
557
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

642
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
642
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

527
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
527
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

550
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
550
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

324
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

361
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
361

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stauffer syndrome : a rare paraneoplastic complication of renal cell carcinoma to be kept in mind. Case report and literature survey.

Acta gastro-enterologica Belgica·2024
Same author

Patient management after primary rectal cancer diagnosis. Special focus on surgical treatment for non-metastatic disease.

Acta chirurgica Belgica·2023
Same author

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

[Demons-Meigs syndrome secondary to an ovarian Brenner tumour. Case report and literature survey].

Revue medicale de Liege·2018
Same author

[Cancer recurrence or sarcoidosis: the essential contribution of pathology].

Revue medicale de Liege·2014

Related Experiment Video

Updated: Apr 3, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.4K

[pericarditis following 5-fluorouracil administration].

S Maréchal, V Racaru, G Houbiers

    Revue Medicale De Liege
    |September 18, 2015
    PubMed
    Summary

    A rare case of pericarditis occurred after 5-fluorouracil chemotherapy for rectal cancer. Monitoring patients for cardiac risks and prompt treatment are crucial for managing this uncommon side effect.

    Area of Science:

    • Oncology
    • Cardiology
    • Pharmacology

    Background:

    • Metastatic rectal cancer treatment often involves chemotherapy.
    • 5-fluorouracil (5-FU) is a common chemotherapeutic agent with known toxicities.
    • Cardiotoxicity is an infrequent but serious adverse effect of 5-FU.

    Observation:

    • A 52-year-old patient with metastatic rectal cancer developed pericarditis post-5-fluorouracil infusion.
    • Pericarditis is an uncommon clinical presentation of 5-FU-induced cardiotoxicity.
    • The patient's history included metastatic rectal cancer.

    Findings:

    • 5-fluorouracil can induce cardiotoxicity, including pericarditis.
    • Several risk factors for 5-FU cardiotoxicity have been identified.
    • Early identification and management are key.

    More Related Videos

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
    14:24

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

    Published on: January 21, 2018

    12.3K
    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
    05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    9.8K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Implantation of Total Artificial Heart in Congenital Heart Disease
    07:27

    Implantation of Total Artificial Heart in Congenital Heart Disease

    Published on: July 18, 2014

    25.4K
    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
    14:24

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

    Published on: January 21, 2018

    12.3K
    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
    05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    9.8K

    Implications:

    • Close patient monitoring is essential during 5-fluorouracil therapy, especially for those at risk.
    • Discontinuation of 5-fluorouracil and substitution with an alternative agent is the primary treatment strategy.
    • Understanding and managing rare side effects like pericarditis improves patient outcomes in cancer care.